{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:58:43Z","timestamp":1789217923620,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["5R01EY010804"],"award-info":[{"award-number":["5R01EY010804"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS079965"],"award-info":[{"award-number":["1R01NS079965"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA 964119"],"award-info":[{"award-number":["MDA 964119"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000183","name":"United States Department of Defense | United States Army | U.S. Army Research, Development and Engineering Command | Army Research Office","doi-asserted-by":"publisher","award":["W911NF-21-1-0248"],"award-info":[{"award-number":["W911NF-21-1-0248"]}],"id":[{"id":"10.13039\/100000183","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nuclease-mediated editing of heteroplasmic mitochondrial DNA (mtDNA) seeks to preferentially cleave and eliminate mutant mtDNA, leaving wild-type genomes to repopulate the cell and shift mtDNA heteroplasmy. Various technologies are available, but many suffer from limitations based on size and\/or specificity. The use of ARCUS nucleases, derived from naturally occurring I-\n                    <jats:italic>Cre<\/jats:italic>\n                    I, avoids these pitfalls due to their small size, single-component protein structure and high specificity resulting from a robust protein-engineering process. Here we describe the development of a mitochondrial-targeted ARCUS (mitoARCUS) nuclease designed to target one of the most common pathogenic mtDNA mutations, m.3243A&gt;G. mitoARCUS robustly eliminated mutant mtDNA without cutting wild-type mtDNA, allowing for shifts in heteroplasmy and concomitant improvements in mitochondrial protein steady-state levels and respiration. In vivo efficacy was demonstrated using a m.3243A&gt;G xenograft mouse model with mitoARCUS delivered systemically by adeno-associated virus. Together, these data support the development of mitoARCUS as an in vivo gene-editing therapeutic for m.3243A&gt;G-associated diseases.\n                  <\/jats:p>","DOI":"10.1038\/s42255-023-00932-6","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T12:01:49Z","timestamp":1701345709000},"page":"2169-2183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Efficient elimination of MELAS-associated m.3243G mutant mitochondrial DNA by an engineered mitoARCUS nuclease"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8071-625X","authenticated-orcid":false,"given":"Wendy K.","family":"Shoop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janel","family":"Lape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Trum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alea","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Sevigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Mischler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra R.","family":"Bacman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0509-3835","authenticated-orcid":false,"given":"Flavia","family":"Fontanesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Jantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6993-6910","authenticated-orcid":false,"given":"Cassandra L.","family":"Gorsuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-7092","authenticated-orcid":false,"given":"Carlos T.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"932_CR1","doi-asserted-by":"publisher","first-page":"SI17","DOI":"10.1016\/S0140-6736(99)90244-1","volume":"354","author":"PF Chinnery","year":"1999","unstructured":"Chinnery, P. F. & Turnbull, D. M. Mitochondrial DNA and disease. Lancet 354, SI17\u2013SI21 (1999).","journal-title":"Lancet"},{"key":"932_CR2","doi-asserted-by":"publisher","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","volume":"2","author":"GS Gorman","year":"2016","unstructured":"Gorman, G. S. et al. Mitochondrial diseases. Nat. Rev. Dis. Prim. 2, 16080 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"932_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/290457a0","volume":"290","author":"S Anderson","year":"1981","unstructured":"Anderson, S. et al. Sequence and organization of the human mitochondrial genome. Nature 290, 457\u2013465 (1981).","journal-title":"Nature"},{"key":"932_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/13779","volume":"23","author":"RM Andrews","year":"1999","unstructured":"Andrews, R. M. et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet. 23, 147 (1999).","journal-title":"Nat. Genet."},{"key":"932_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ana.24362","volume":"77","author":"GS Gorman","year":"2015","unstructured":"Gorman, G. S. et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann. Neurol. 77, 753\u2013759 (2015).","journal-title":"Ann. Neurol."},{"key":"932_CR6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.molmed.2020.02.006","volume":"26","author":"CB Jackson","year":"2020","unstructured":"Jackson, C. B., Turnbull, D. M., Minczuk, M. & Gammage, P. A. Therapeutic manipulation of mtDNA heteroplasmy: a shifting perspective. Trends Mol. Med. 26, 698\u2013709 (2020).","journal-title":"Trends Mol. Med."},{"key":"932_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.410160409","volume":"16","author":"SG Pavlakis","year":"1984","unstructured":"Pavlakis, S. G., Phillips, P. C., DiMauro, S., De Vivo, D. C. & Rowland, L. P. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann. Neurol. 16, 481\u2013488 (1984).","journal-title":"Ann. Neurol."},{"key":"932_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","volume":"1820","author":"S Yatsuga","year":"2012","unstructured":"Yatsuga, S. et al. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim. Biophys. Acta 1820, 619\u2013624 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"932_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0960-8966(92)90045-8","volume":"2","author":"M Hirano","year":"1992","unstructured":"Hirano, M. et al. MELAS: an original case and clinical criteria for diagnosis. Neuromuscul. Disord. 2, 125\u2013135 (1992).","journal-title":"Neuromuscul. Disord."},{"key":"932_CR10","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1212\/WNL.0b013e31823a0c7f","volume":"77","author":"P Kaufmann","year":"2011","unstructured":"Kaufmann, P. et al. Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype. Neurology 77, 1965\u20131971 (2011).","journal-title":"Neurology"},{"key":"932_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","volume":"116","author":"AW El-Hattab","year":"2015","unstructured":"El-Hattab, A. W., Adesina, A. M., Jones, J. & Scaglia, F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol. Genet. Metab. 116, 4\u201312 (2015).","journal-title":"Mol. Genet. Metab."},{"key":"932_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/mus.20807","volume":"36","author":"LJC Wong","year":"2007","unstructured":"Wong, L. J. C. Pathogenic mitochondrial DNA mutations in protein-coding genes. Muscle Nerve 36, 279\u2013293 (2007).","journal-title":"Muscle Nerve"},{"key":"932_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00019052-199610000-00010","volume":"9","author":"CT Moraes","year":"1996","unstructured":"Moraes, C. T. Mitochondrial disorders. Curr. Opin. Neurol. 9, 369\u2013374 (1996).","journal-title":"Curr. Opin. Neurol."},{"key":"932_CR14","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1056\/NEJM199404073301403","volume":"330","author":"T Kadowaki","year":"1994","unstructured":"Kadowaki, T. et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N. Engl. J. Med. 330, 962\u2013968 (1994).","journal-title":"N. Engl. J. Med."},{"key":"932_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ana.410430313","volume":"43","author":"CM Sue","year":"1998","unstructured":"Sue, C. M. et al. Cochlear origin of hearing loss in MELAS syndrome. Ann. Neurol. 43, 350\u2013359 (1998).","journal-title":"Ann. Neurol."},{"key":"932_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.mito.2006.12.004","volume":"7","author":"N Manwaring","year":"2007","unstructured":"Manwaring, N. et al. Population prevalence of the MELAS A3243G mutation. Mitochondrion 7, 230\u2013233 (2007).","journal-title":"Mitochondrion"},{"key":"932_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0006-291X(92)90517-O","volume":"183","author":"RJ Wiesner","year":"1992","unstructured":"Wiesner, R. J., R\u00fcegg, J. C. & Morano, I. Counting target molecules by exponential polymerase chain reaction: copy number of mitochondrial DNA in rat tissues. Biochem. Biophys. Res. Commun. 183, 553\u2013559 (1992).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"932_CR18","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/nar\/gng060","volume":"31","author":"FJ Miller","year":"2003","unstructured":"Miller, F. J., Rosenfeldt, F. L., Zhang, C., Linnane, A. W. & Nagley, P. Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age. Nucleic Acids Res. 31, e61 (2003).","journal-title":"Nucleic Acids Res."},{"key":"932_CR19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35072063","volume":"2","author":"J Smeitink","year":"2001","unstructured":"Smeitink, J., Van Den Heuvel, L. & DiMauro, S. The genetics and pathology of oxidative phosphorylation. Nat. Rev. Genet. 2, 342\u2013352 (2001).","journal-title":"Nat. Rev. Genet."},{"key":"932_CR20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1146\/annurev.biochem.76.060305.152028","volume":"76","author":"M Falkenberg","year":"2007","unstructured":"Falkenberg, M., Larsson, N. G. & Gustafsson, C. M. DNA replication and transcription in mammalian mitochondria. Annu. Rev. Biochem. 76, 679\u2013699 (2007).","journal-title":"Annu. Rev. Biochem."},{"key":"932_CR21","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/hmg\/ddn073","volume":"17","author":"S Sacconi","year":"2008","unstructured":"Sacconi, S. et al. A functionally dominant mitochondrial DNA mutation. Hum. Mol. Genet. 17, 1814\u20131820 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"932_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1042\/bj20021594","volume":"370","author":"R Rossignol","year":"2003","unstructured":"Rossignol, R. et al. Mitochondrial threshold effects. Biochem. J. 370, 751\u2013762 (2003).","journal-title":"Biochem. J."},{"key":"932_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nrg3966","volume":"16","author":"JB Stewart","year":"2015","unstructured":"Stewart, J. B. & Chinnery, P. F. The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease. Nat. Rev. Genet. 16, 530\u2013542 (2015).","journal-title":"Nat. Rev. Genet."},{"key":"932_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.tig.2022.04.011","volume":"38","author":"JD Barrera-Paez","year":"2022","unstructured":"Barrera-Paez, J. D. & Moraes, C. T. Mitochondrial genome engineering coming-of-age. Trends Genet. 38, 869\u2013880 (2022).","journal-title":"Trends Genet."},{"key":"932_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/joim.13055","volume":"287","author":"U Zekonyte","year":"2020","unstructured":"Zekonyte, U., Bacman, S. R. & Moraes, C. T. DNA-editing enzymes as potential treatments for heteroplasmic mtDNA diseases. J. Intern. Med. 287, 685\u2013697 (2020).","journal-title":"J. Intern. Med."},{"key":"932_CR26","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1016\/j.csbj.2021.06.003","volume":"19","author":"X Yang","year":"2021","unstructured":"Yang, X., Jiang, J., Li, Z., Liang, J. & Xiang, Y. Strategies for mitochondrial gene editing. Comput. Struct. Biotechnol. J. 19, 3319\u20133329 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"932_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s10439-022-03051-7","author":"N Mikhailov","year":"2022","unstructured":"Mikhailov, N. & H\u00e4m\u00e4l\u00e4inen, R. H. Modulating mitochondrial DNA heteroplasmy with mitochondrially targeted endonucleases. Ann. Biomed. Eng. https:\/\/doi.org\/10.1007\/s10439-022-03051-7 (2022).","journal-title":"Ann. Biomed. Eng."},{"key":"932_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04895-1","volume":"9","author":"N Nissanka","year":"2018","unstructured":"Nissanka, N., Bacman, S. R., Plastini, M. J. & Moraes, C. T. The mitochondrial DNA polymerase gamma degrades linear DNA fragments precluding the formation of deletions. Nat. Commun. 9, 2491 (2018).","journal-title":"Nat. Commun."},{"key":"932_CR29","doi-asserted-by":"publisher","first-page":"a012641","DOI":"10.1101\/cshperspect.a012641","volume":"5","author":"M Alexeyev","year":"2013","unstructured":"Alexeyev, M., Shokolenko, I., Wilson, G. & Ledoux, S. The maintenance of mitochondrial DNA integrity-critical analysis and update. Cold Spring Harb. Perspect. Biol. 5, a012641 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"932_CR30","doi-asserted-by":"publisher","first-page":"e0176795","DOI":"10.1371\/journal.pone.0176795","volume":"12","author":"A Moretton","year":"2017","unstructured":"Moretton, A. et al. Selective mitochondrial DNA degradation following double-strand breaks. PLoS ONE 12, e0176795 (2017).","journal-title":"PLoS ONE"},{"key":"932_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04131-w","volume":"9","author":"V Peeva","year":"2018","unstructured":"Peeva, V. et al. Linear mitochondrial DNA is rapidly degraded by components of the replication machinery. Nat. Commun. 9, 1727 (2018).","journal-title":"Nat. Commun."},{"key":"932_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0168-9525(01)02238-7","volume":"17","author":"CT Moraes","year":"2001","unstructured":"Moraes, C. T. What regulates mitochondrial DNA copy number in animal cells? Trends Genet. 17, 199\u2013205 (2001).","journal-title":"Trends Genet."},{"key":"932_CR33","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.mito.2011.05.004","volume":"11","author":"PJ Carling","year":"2011","unstructured":"Carling, P. J., Cree, L. M. & Chinnery, P. F. The implications of mitochondrial DNA copy number regulation during embryogenesis. Mitochondrion 11, 686\u2013692 (2011).","journal-title":"Mitochondrion"},{"key":"932_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1673-8527(08)60099-5","volume":"36","author":"LL Clay Montier","year":"2009","unstructured":"Clay Montier, L. L., Deng, J. J. & Bai, Y. Number matters: control of mammalian mitochondrial DNA copy number. J. Genet. Genomics 36, 125\u2013131 (2009).","journal-title":"J. Genet. Genomics"},{"key":"932_CR35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/emmm.201303672","volume":"6","author":"PA Gammage","year":"2014","unstructured":"Gammage, P. A., Rorbach, J., Vincent, A. I., Rebar, E. J. & Minczuk, M. Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations. EMBO Mol. Med. 6, 458\u2013466 (2014).","journal-title":"EMBO Mol. Med."},{"key":"932_CR36","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/mt.2015.126","volume":"23","author":"M Hashimoto","year":"2015","unstructured":"Hashimoto, M. et al. MitoTALEN: a general approach to reduce mutant mtDNA loads and restore oxidative phosphorylation function in mitochondrial diseases. Mol. Ther. 23, 1592\u20131599 (2015).","journal-title":"Mol. Ther."},{"key":"932_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15871-y","volume":"7","author":"N Yahata","year":"2017","unstructured":"Yahata, N., Matsumoto, Y., Omi, M., Yamamoto, N. & Hata, R. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation. Sci. Rep. 7, 15557 (2017).","journal-title":"Sci. Rep."},{"key":"932_CR38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cell.2015.03.051","volume":"161","author":"P Reddy","year":"2015","unstructured":"Reddy, P. et al. Selective elimination of mitochondrial mutations in the germline by genome editing. Cell 161, 459\u2013469 (2015).","journal-title":"Cell"},{"key":"932_CR39","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41591-018-0166-8","volume":"24","author":"SR Bacman","year":"2018","unstructured":"Bacman, S. R. et al. MitoTALEN reduces mutant mtDNA load and restores tRNA-Ala levels in a mouse model of heteroplasmic mtDNA mutation. Nat. Med. 24, 1696\u20131700 (2018).","journal-title":"Nat. Med."},{"key":"932_CR40","doi-asserted-by":"publisher","first-page":"e8084","DOI":"10.15252\/emmm.201708084","volume":"10","author":"CV Pereira","year":"2018","unstructured":"Pereira, C. V. et al. mitoTev\u2010TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels. EMBO Mol. Med. 10, e8084 (2018).","journal-title":"EMBO Mol. Med."},{"key":"932_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s13238-017-0499-y","volume":"9","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs. Protein Cell 9, 283\u2013297 (2018).","journal-title":"Protein Cell"},{"key":"932_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23561-7","volume":"12","author":"U Zekonyte","year":"2021","unstructured":"Zekonyte, U. et al. Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo. Nat. Commun. 12, 3210 (2021).","journal-title":"Nat. Commun."},{"key":"932_CR43","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0378-1119(92)90278-W","volume":"119","author":"AJ Thompson","year":"1992","unstructured":"Thompson, A. J., Yuan, X., Kudlicki, W. & Herrin, D. L. Cleavage and recognition pattern of a double-strand-specific endonuclease (I-CreI) encoded by the chloroplast 23S rRNA intron of Chlamydomonas reinhardtii. Gene 119, 247\u2013251 (1992).","journal-title":"Gene"},{"key":"932_CR44","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ymthe.2017.02.005","volume":"25","author":"DT MacLeod","year":"2017","unstructured":"MacLeod, D. T. et al. Integration of a CD19 CAR into the TCR alpha chain locus streamlines production of allogeneic gene-edited CAR T cells. Mol. Ther. 25, 949\u2013961 (2017).","journal-title":"Mol. Ther."},{"key":"932_CR45","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nbt.4182","volume":"36","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol. Nat. Biotechnol. 36, 717\u2013725 (2018).","journal-title":"Nat. Biotechnol."},{"key":"932_CR46","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.ymthe.2021.02.020","volume":"29","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivo genome editing of PCSK9. Mol. Ther. 29, 2019\u20132029 (2021).","journal-title":"Mol. Ther."},{"key":"932_CR47","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1016\/j.ymthe.2022.05.013","volume":"30","author":"CL Gorsuch","year":"2022","unstructured":"Gorsuch, C. L. et al. Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo. Mol. Ther. 30, 2909\u20132922 (2022).","journal-title":"Mol. Ther."},{"key":"932_CR48","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1089\/hum.2021.108","volume":"33","author":"JA Greig","year":"2022","unstructured":"Greig, J. A. et al. Treating transthyretin amyloidosis via adeno-associated virus vector delivery of meganucleases. Hum. Gene Ther. 33, 1174\u20131186 (2022).","journal-title":"Hum. Gene Ther."},{"key":"932_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0960-8966(93)90040-Q","volume":"3","author":"CT Moraes","year":"1993","unstructured":"Moraes, C. T. et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul. Disord. 3, 43\u201350 (1993).","journal-title":"Neuromuscul. Disord."},{"key":"932_CR50","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1136\/jmedgenet-2015-103576","volume":"53","author":"CL Alston","year":"2016","unstructured":"Alston, C. L. et al. A recurrent mitochondrial p.Trp22Arg NDUFB3 variant causes a distinctive facial appearance, short stature and a mild biochemical and clinical phenotype. J. Med Genet. 53, 634\u2013641 (2016).","journal-title":"J. Med Genet."},{"key":"932_CR51","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1046\/j.1432-1327.2001.02140.x","volume":"268","author":"S Rodr\u00edguez-Enr\u00edquez","year":"2001","unstructured":"Rodr\u00edguez-Enr\u00edquez, S., Ju\u00e1rez, O., Rodr\u00edguez-Zavala, J. S. & Moreno-S\u00e1nchez, R. Multisite control of the Crabtree effect in ascites hepatoma cells. Eur. J. Biochem. 268, 2512\u20132519 (2001).","journal-title":"Eur. J. Biochem."},{"key":"932_CR52","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt, S. Y. & Vander Heiden, M. G. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 27, 441\u2013464 (2011).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"932_CR53","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","volume":"97","author":"LD Marroquin","year":"2007","unstructured":"Marroquin, L. D., Hynes, J., Dykens, J. A., Jamieson, J. D. & Will, Y. Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicol. Sci. 97, 539\u2013547 (2007).","journal-title":"Toxicol. Sci."},{"key":"932_CR54","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.biocel.2016.08.029","volume":"79","author":"AI Mot","year":"2016","unstructured":"Mot, A. I., Liddell, J. R., White, A. R. & Crouch, P. J. Circumventing the Crabtree effect: a method to induce lactate consumption and increase oxidative phosphorylation in cell culture. Int. J. Biochem. Cell Biol. 79, 128\u2013138 (2016).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"932_CR55","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41586-022-04836-5","volume":"606","author":"Z Lei","year":"2022","unstructured":"Lei, Z. et al. Mitochondrial base editor induces substantial nuclear off-target mutations. Nature 606, 804\u2013811 (2022).","journal-title":"Nature"},{"key":"932_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41421-022-00391-5","volume":"8","author":"Y Wei","year":"2022","unstructured":"Wei, Y. et al. Mitochondrial base editor DdCBE causes substantial DNA off-target editing in nuclear genome of embryos. Cell Discov. 8, 27 (2022).","journal-title":"Cell Discov."},{"key":"932_CR57","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1093\/hmg\/10.26.3093","volume":"10","author":"S Srivastava","year":"2001","unstructured":"Srivastava, S. & Moraes, C. T. Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease. Hum. Mol. Genet. 10, 3093\u20133099 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"932_CR58","first-page":"534","volume":"9","author":"M Tanaka","year":"2002","unstructured":"Tanaka, M. et al. Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria. J. Biomed. Sci. 9, 534\u2013541 (2002).","journal-title":"J. Biomed. Sci."},{"key":"932_CR59","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/gt.2008.11","volume":"15","author":"MF Alexeyev","year":"2008","unstructured":"Alexeyev, M. F. et al. Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes. Gene Ther. 15, 516\u2013523 (2008).","journal-title":"Gene Ther."},{"key":"932_CR60","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/sj.gt.3302981","volume":"14","author":"SR Bacman","year":"2007","unstructured":"Bacman, S. R., Williams, S. L., Hernandez, D. & Moraes, C. T. Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a \u2018differential multiple cleavage-site\u2019 model. Gene Ther. 14, 1309\u20131318 (2007).","journal-title":"Gene Ther."},{"key":"932_CR61","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/gt.2010.25","volume":"17","author":"SR Bacman","year":"2010","unstructured":"Bacman, S. R., Williams, S. L., Garcia, S. & Moraes, C. T. Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease. Gene Ther. 17, 713\u2013720 (2010).","journal-title":"Gene Ther."},{"key":"932_CR62","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/gt.2011.196","volume":"19","author":"SR Bacman","year":"2012","unstructured":"Bacman, S. R., Williams, S. L., Duan, D. & Moraes, C. T. Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria targeted restriction endonuclease. Gene Ther. 19, 1101\u20131106 (2012).","journal-title":"Gene Ther."},{"key":"932_CR63","doi-asserted-by":"publisher","first-page":"14392","DOI":"10.1073\/pnas.0502896102","volume":"102","author":"MP Bayona-Bafaluy","year":"2005","unstructured":"Bayona-Bafaluy, M. P., Blits, B., Battersby, B. J., Shoubridge, E. A. & Moraes, C. T. Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease. Proc. Natl Acad. Sci. USA 102, 14392\u201314397 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"932_CR64","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/nm.3261","volume":"19","author":"SR Bacman","year":"2013","unstructured":"Bacman, S. R., Williams, S. L., Pinto, M., Peralta, S. & Moraes, C. T. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat. Med. 19, 1111\u20131113 (2013).","journal-title":"Nat. Med."},{"key":"932_CR65","doi-asserted-by":"publisher","first-page":"7804","DOI":"10.1093\/nar\/gkw676","volume":"44","author":"PA Gammage","year":"2016","unstructured":"Gammage, P. A. et al. Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs. Nucleic Acids Res. 44, 7804\u20137816 (2016).","journal-title":"Nucleic Acids Res."},{"key":"932_CR66","doi-asserted-by":"publisher","first-page":"19689","DOI":"10.1073\/pnas.0609502103","volume":"103","author":"M Minczuk","year":"2006","unstructured":"Minczuk, M., Papworth, M. A., Kolasinska, P., Murphy, M. P. & Klug, A. Sequence-specific modification of mitochondrial DNA using a chimeric zinc finger methylase. Proc. Natl Acad. Sci. USA 103, 19689\u201319694 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"932_CR67","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/s41591-018-0165-9","volume":"24","author":"PA Gammage","year":"2018","unstructured":"Gammage, P. A. et al. Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo. Nat. Med. 24, 1691\u20131695 (2018).","journal-title":"Nat. Med."},{"key":"932_CR68","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1093\/nar\/gks320","volume":"40","author":"R Molina","year":"2012","unstructured":"Molina, R. et al. Non-specific protein-DNA interactions control I-CreI target binding and cleavage. Nucleic Acids Res. 40, 6936\u20136945 (2012).","journal-title":"Nucleic Acids Res."},{"key":"932_CR69","doi-asserted-by":"publisher","first-page":"148365","DOI":"10.1016\/j.bbabio.2020.148365","volume":"1862","author":"K Szczepanowska","year":"2021","unstructured":"Szczepanowska, K. & Trifunovic, A. Tune instead of destroy: how proteolysis keeps OXPHOS in shape. Biochim. Biophys. Acta Bioenerg. 1862, 148365 (2021).","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"932_CR70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jim.2014.05.014","volume":"408","author":"M Zhang","year":"2014","unstructured":"Zhang, M. et al. The impact of Nucleofection\u00ae on the activation state of primary human CD4 T cells. J. Immunol. Methods 408, 123\u2013131 (2014).","journal-title":"J. Immunol. Methods"},{"key":"932_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2383-6","volume":"11","author":"Winanto","year":"2020","unstructured":"Winanto, Khong, Z. J., Soh, B.-S., Fan, Y. & Ng, S.-Y. Organoid cultures of MELAS neural cells reveal hyperactive Notch signaling that impacts neurodevelopment. Cell Death Dis. 11, 182 (2020).","journal-title":"Cell Death Dis."},{"key":"932_CR72","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/mt.2009.71","volume":"17","author":"S Duque","year":"2009","unstructured":"Duque, S. et al. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol. Ther. 17, 1187\u20131196 (2009).","journal-title":"Mol. Ther."},{"key":"932_CR73","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/mt.2011.157","volume":"19","author":"AK Bevan","year":"2011","unstructured":"Bevan, A. K. et al. Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders. Mol. Ther. 19, 1971\u20131980 (2011).","journal-title":"Mol. Ther."},{"key":"932_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/srep00253","volume":"2","author":"B Dehay","year":"2012","unstructured":"Dehay, B., Dalkara, D., Dovero, S., Li, Q. & Bezard, E. Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques. Sci. Rep. 2, 253 (2012).","journal-title":"Sci. Rep."},{"key":"932_CR75","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med. 377, 1713\u20131722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"932_CR76","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41591-022-01866-4","volume":"28","author":"KA Strauss","year":"2022","unstructured":"Strauss, K. A. et al. Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial. Nat. Med. 28, 1381\u20131389 (2022).","journal-title":"Nat. Med."},{"key":"932_CR77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust, K. D. et al. Intravascular AAV9 preferentially targets neonatal-neurons and adult-astrocytes in CNS. Nat. Biotechnol. 27, 59\u201365 (2009).","journal-title":"Nat. Biotechnol."},{"key":"932_CR78","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2014.210","volume":"23","author":"K Meyer","year":"2015","unstructured":"Meyer, K. et al. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates. Mol. Ther. 23, 477\u2013487 (2015).","journal-title":"Mol. Ther."},{"key":"932_CR79","doi-asserted-by":"crossref","unstructured":"Bacman, S. R., Nissanka, N. & Moraes, C. T. Cybrid Technology. Methods in Cell Biology, Vol. 155 (Elsevier, 2020).","DOI":"10.1016\/bs.mcb.2019.11.025"},{"key":"932_CR80","doi-asserted-by":"publisher","first-page":"10307","DOI":"10.1128\/JVI.76.20.10307-10319.2002","volume":"76","author":"V Eichwald","year":"2002","unstructured":"Eichwald, V., Daeffler, L., Klein, M., Rommelaere, J. & Salom\u00e9, N. The NS2 proteins of parvovirus minute virus of mice are required for efficient nuclear egress of progeny virions in mouse cells. J. Virol. 76, 10307\u201310319 (2002).","journal-title":"J. Virol."},{"key":"932_CR81","doi-asserted-by":"publisher","first-page":"102574","DOI":"10.1016\/j.jbc.2022.102574","volume":"298","author":"WK Shoop","year":"2022","unstructured":"Shoop, W. K., Gorsuch, C. L., Bacman, S. R. & Moraes, C. T. Precise and simultaneous quantification of mitochondrial DNA heteroplasmy and copy number by digital PCR. J. Biol. Chem. 298, 102574 (2022).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-023-00932-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-023-00932-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-023-00932-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T03:09:09Z","timestamp":1703041749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-023-00932-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":81,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["932"],"URL":"https:\/\/doi.org\/10.1038\/s42255-023-00932-6","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"18 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.K.S., J.L., M.T., A.P., E.S., A.M., J.S., D.J. and C.L.G. received compensation as employees of Precision BioSciences, Inc. J.S. and D.J. are founders of Precision BioSciences, Inc. C.T.M. is part of a patent application, along with Precision BioSciences. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}